WHIPPANY, N.J.--(BUSINESS WIRE)--New post-hoc analyses from the investigational Phase III ARANOTE trial showed a clinically meaningful improvement in health-related quality of life (HRQoL) and delayed pain progression for metastatic castration-sensitive prostate cancer (mCSPC) patients treated with NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) versus patients treated with place...
Tariff turmoil and market downturn are creating buying opportunities for investors looking to capitalize on panic selling and fear. The US-China trade war and rotation from U.S. assets, declining USD, and uncertainty surrounding monetary policy have prompted many investors to de-risk and seek value. Some of the greatest value and growth opportunities can be found in diversifying portfolios with...
While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the leader in smart home security solutions, in collaboration with Yale and the Z-Wave Alliance , today announced the launch of the Yale Assure Lock 2 Touch with Z-Wave for ADT+ .
WHIPPANY, N.J.--(BUSINESS WIRE)--AUA 2025: New Data from Post-Hoc Analyses Shared on Ultra-Low PSA Response in Patients with mHSPC Receiving NUBEQA® (darolutamide) plus ADT.
I maintain a buy rating for ADT, driven by solid 1Q25 results, improved fundamentals, and promising growth prospects with the ADT+ platform. ADT's 1Q25 earnings showed 7% y/y revenue growth, margin expansion, and a record-low customer churn rate, highlighting the essential nature of its services. The ADT+ Translator and Trusted Neighbor features are strategic upgrades, enhancing customer retent...
ADT Inc. (NYSE:ADT ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Elizabeth Landers - Investor Relations Jim DeVries - Chairman, President & Chief Executive Officer Jeff Likosar - Chief Financial Officer Conference Call Participants Ronan Kennedy - Barclays George Tong - Goldman Sachs David Paige - RBC Capital Markets Peter Christiansen - Citigroup Yehuda Sil...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.